Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK/PD of Daprodustat in Healthy Subjects
NCT02348372Phase 1Completed
- Sponsor
- GSK
- Start
- Mar 2011
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of daprodustat in anemia (5 arms), sponsored by GSK. Primary endpoints: Number of Participants with Adverse Events as a Measure of Safety and Tolerability, AUC(0-t), AUC(0-∞), Cmax, tmax and t½ of GSK1278863A and 3 more. Started Mar 2011; status: completed.
02
Drugs
daprodustat
03
Conditions
anemia
Beyond the preview
Go deeper on NCT02348372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02348372.